UNITED THERAPEUTICS Corp (NASDAQ:UTHR)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Keeps a healthy share of every dollar it sells.
- Revenue
- $3.15B
- Net income
- $1.31B
- Net margin
- 41.6%
Little or no net debt.
- Total debt
- $0
- Cash
- $1.80B
- Net debt / EBITDA
- -1.08x
Comfortably covers what is due within a year.
- Current assets
- $3.48B
- Current liabilities
- $607.8M
- Current ratio
- 5.73
The business funds itself from operations.
- Operating cash flow
- $1.69B
- Free cash flow
- $1.09B
- FCF margin
- 34.6%
Not funding itself by issuing shares.
- Shares outstanding
- 42.6M
- Share growth (1y)
- -5.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
UTHR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 783.30 M | 781.50 M | 790.20 M | 799.50 M | 798.60 M | 794.40 M |
| Revenue Growth (YoY) | -1.92 % | -1.62 % | 7.38 % | 6.76 % | 11.71 % | 17.22 % |
| Cost of Revenue | 99.50 M | 133.40 M | 103.40 M | 100.90 M | 87.60 M | 92.50 M |
| Gross Profit | 683.80 M | 648.10 M | 686.80 M | 698.60 M | 711.00 M | 701.90 M |
| SG&A Expense | 175.20 M | 184.10 M | 189.80 M | 181.80 M | 190.80 M | 170.10 M |
| R&D Expense | 146.30 M | 138.20 M | 139.50 M | 127.50 M | 134.00 M | 149.00 M |
| Operating Expenses | 353.00 M | 322.30 M | 329.30 M | 309.30 M | 346.50 M | 319.10 M |
| Operating Income | 330.80 M | 325.80 M | 357.50 M | 389.30 M | 364.50 M | 382.80 M |
| Pretax Income | 372.70 M | 318.30 M | 444.00 M | 438.00 M | 408.40 M | 423.50 M |
| Tax Provision | 39.70 M | 43.40 M | 79.70 M | 99.30 M | 98.90 M | 101.30 M |
| Net Income | 333.00 M | 274.90 M | 364.30 M | 338.70 M | 309.50 M | 322.20 M |
| EPS (Basic) | 7.82 | 6.32 | 8.36 | 7.73 | 6.86 | 7.18 |
| EPS (Diluted) | 7.27 | 5.82 | 7.66 | 7.16 | 6.41 | 6.63 |
| Shares Outstanding | 42.60 M | 43.50 M | 44.30 M | 43.80 M | 45.10 M | 44.90 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.